article thumbnail

DEA Publishes Notice of Proposed Rulemaking On Marijuana Research

Cannabis Law Report

The Notice of Proposed Rulemaking, published in the Federal Register today for public inspection, provides details on the proposed process for administering the new program. The DEA says the proposed rule will see additional registered growers and more diverse variety of marijuana strains available for research.

DEA 80
article thumbnail

Press Release: DEA proposes process to expand marijuana research in the United States

Cannabis Law Report

The new approach will expand opportunities for marijuana growers who seek to grow marijuana for research purposes and outline the agency’s proposed process for administering the new program, consistent with applicable law.

DEA 97
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

USA Dept of Justice Press Release: DEA Announces Steps Necessary to Improve Access to Marijuana Research

Cannabis Law Report

DEA Announces Steps Necessary to Improve Access to Marijuana Research. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. percent delta-9 THC threshold, is not a controlled substance, and a DEA registration is not required to grow or research it.

DEA 59
article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA. More CBD Coverage.

DEA 51
article thumbnail

U.S. Cannabis Legalization Update: Who’s Still Waiting and Who May Legalize

Veriheal

In the meantime, the state allows CBD extracts for treating qualifying health conditions with less than 0.9% Despite these strict regulations, in 2014, the state legalized the use of CBD-rich cannabis extracts to treat intractable seizures. The only stipulation is that the extract has less than 0.9% year prison sentence.

article thumbnail

Empire State Cannabis Update: CCB Makes Progress In Hemp Program & Chair Hints At Adult-Use Timeline

Cannabis Law Report

Cannabinoid Hemp Program Regulations (Finally) Finalized. While much attention is focused on New York’s adult-use cannabis market, the CCB and Office of Cannabis Management (OCM) are also responsible for overseeing both the Medical Marijuana and Cannabinoid Hemp Programs. cannabinoid hemp and hemp extract.”

article thumbnail

Hemp-CBD: Deadline Approaching to Submit Comments on USDA Interim Hemp Rule

Canna Law Blog

That is the DEA’s interim final rule suggesting that in-process hemp extract shall be treated as a schedule I controlled substance during any point at which its THC concentration exceeds 0.3 The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. The 2018 Farm Bill Does Not Support the DEA Interim Rule.

Hemp 87